Published in Cortex on February 14, 2012
Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. J Behav Addict (2014) 1.02
Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol (2014) 0.96
Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J Neurosci (2014) 0.89
The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement. PLoS One (2013) 0.88
Developmental imaging genetics: linking dopamine function to adolescent behavior. Brain Cogn (2013) 0.87
Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing. Front Hum Neurosci (2013) 0.83
Fear-potentiated startle during extinction is associated with white matter microstructure and functional connectivity. Cortex (2014) 0.82
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Transl Psychiatry (2016) 0.80
Common variants in DRD2 are associated with sleep duration: the CARe consortium. Hum Mol Genet (2015) 0.79
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry (2017) 0.78
GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors. eNeuro (2016) 0.77
Genetic variations in COMT and DRD2 modulate attentional bias for affective facial expressions. PLoS One (2013) 0.77
New repeat polymorphism in the AKT1 gene predicts striatal dopamine D2/D3 receptor availability and stimulant-induced dopamine release in the healthy human brain. J Neurosci (2017) 0.76
Adolescent neurobiological susceptibility to social context. Dev Cogn Neurosci (2015) 0.76
The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces. Brain Behav (2015) 0.75
Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effects. J Psychopharmacol (2014) 0.75
Activation of the DLPFC Reveals an Asymmetric Effect in Risky Decision Making: Evidence from a tDCS Study. Front Psychol (2017) 0.75
Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity. Biol Res Nurs (2015) 0.75
Looking for reward in all the wrong places: dopamine receptor gene polymorphisms indirectly affect aggression through sensation-seeking. Soc Neurosci (2015) 0.75
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage (2003) 24.48
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev (1998) 12.19
Dopamine, learning and motivation. Nat Rev Neurosci (2004) 11.97
The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology (2010) 10.17
Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage (2002) 9.66
Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry (1999) 7.87
Behavioral theories and the neurophysiology of reward. Annu Rev Psychol (2006) 7.61
Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp (1994) 7.28
Spiral-in/out BOLD fMRI for increased SNR and reduced susceptibility artifacts. Magn Reson Med (2001) 6.57
A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage (2007) 6.01
Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci (1999) 5.15
FMRI visualization of brain activity during a monetary incentive delay task. Neuroimage (2000) 5.15
The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev (1999) 4.77
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A (1998) 4.16
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull (2003) 4.08
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience (2000) 3.95
Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci (1999) 3.80
The subgenual anterior cingulate cortex in mood disorders. CNS Spectr (2008) 3.40
Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J Comp Neurol (1989) 3.17
Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage (2004) 3.15
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal (1997) 3.10
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 3.00
Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci (2000) 2.91
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci (2008) 2.75
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A (2007) 2.62
Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain (2010) 2.34
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci (2002) 2.32
Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry (2007) 2.29
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A (2008) 2.13
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol (2001) 2.12
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
The molecular genetic architecture of human personality: beyond self-report questionnaires. Mol Psychiatry (2006) 2.02
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet (2003) 1.95
Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med (1993) 1.93
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci (2003) 1.92
Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol (1993) 1.89
The cortical dopamine system: role in memory and cognition. Adv Pharmacol (1998) 1.86
Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci (2006) 1.79
mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci (2002) 1.77
Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions. Proc Natl Acad Sci U S A (2009) 1.76
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry (2007) 1.72
The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry (2010) 1.70
Sources of openness/intellect: cognitive and neuropsychological correlates of the fifth factor of personality. J Pers (2005) 1.59
Molecular heterosis: a review. Mol Genet Metab (2000) 1.59
Selective activation of mesocortical DA system by stress. Nature (1976) 1.56
Individual differences in extraversion and dopamine genetics predict neural reward responses. Brain Res Cogn Brain Res (2005) 1.55
Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab (1997) 1.55
Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A (1998) 1.52
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry (2000) 1.43
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain (2008) 1.37
Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. J Neurosci (2009) 1.36
Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience (2009) 1.27
Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging. Neuropsychopharmacology (2010) 1.22
Affective circuitry and risk for alcoholism in late adolescence: differences in frontostriatal responses between vulnerable and resilient children of alcoholic parents. Alcohol Clin Exp Res (2008) 1.22
Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol (2009) 1.21
Effects of stress and aversion on dopamine neurons: implications for addiction. Neurosci Biobehav Rev (2010) 1.21
Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett (2006) 1.20
Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia (2006) 1.15
Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage (2008) 1.12
Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. J Neurosci (2009) 1.11
Integrating rewards and cognition in the frontal cortex. Cogn Affect Behav Neurosci (2004) 1.11
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse (1992) 1.10
Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci U S A (2010) 1.09
Disruption of conditioned reward association by typical and atypical antipsychotics. Pharmacol Biochem Behav (2010) 1.09
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry (1999) 1.09
The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards. Cereb Cortex (2009) 1.05
Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study. Eur J Neurosci (2008) 1.05
Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience (2002) 1.02
Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry (2011) 1.01
Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res (1985) 1.01
COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage (2010) 1.00
Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. Hum Brain Mapp (2010) 0.98
Dopamine is released in the striatum during human emotional processing. Neuroreport (2010) 0.98
Brain imaging, genetics and emotion. Biol Psychol (2008) 0.97
Subregions of the ventral striatum show preferential coding of reward magnitude and probability. Neuroimage (2007) 0.96
Aversive stimuli lead to differential amygdala activation and connectivity patterns depending on catechol-O-methyltransferase Val158Met genotype. Neuroimage (2010) 0.94
Variation in DRD2 dopamine gene predicts Extraverted personality. Neurosci Lett (2009) 0.93
Imaging cognitive anatomy. Trends Cogn Sci (1997) 0.91
The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol Med (2010) 0.90
COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems. Neuroimage (2010) 0.90
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli. Hum Brain Mapp (2010) 0.87
Role of anticipated reward in cognitive behavioral control. Curr Opin Neurobiol (2007) 0.86
Catechol-O-methyltransferase Val158Met genotype affects neural correlates of aversive stimuli processing. Cogn Affect Behav Neurosci (2009) 0.84
Emotional response in dopamine D2L receptor-deficient mice. Behav Brain Res (2008) 0.82
Alcohol consumption is associated with an interaction between DRD2 exon 8 A/A genotype and self-directedness in males. Neuropsychobiology (2007) 0.81
Cognitive and motivational operations in primate prefrontal neurons. Rev Neurosci (1998) 0.79
No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism. Alcohol Clin Exp Res (1996) 0.77
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain (2005) 7.80
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
Convergence of electronic bands for high performance bulk thermoelectrics. Nature (2011) 4.52
Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci (2005) 4.00
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res (2005) 3.94
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med (2010) 3.53
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 3.47
Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry (2006) 3.44
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38
Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A (2007) 3.33
Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13
Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 2.96
Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry (2003) 2.82
BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry (2006) 2.79
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet (2004) 2.71
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet (2002) 2.60
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry (2002) 2.51
Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry (2004) 2.49
Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science (2011) 2.47
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet (2004) 2.45
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet (2003) 2.31
The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med (2009) 2.20
Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci (2007) 2.19
Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain (2004) 2.17
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry (2004) 2.12
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry (2006) 2.09
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway. J Mol Cell Biol (2009) 2.00
A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature (2010) 2.00
Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol (2006) 1.98
Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry (2004) 1.98
Differences in the functional neuroanatomy of inhibitory control across the adult life span. Psychol Aging (2002) 1.88
Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol (2009) 1.81
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry (2008) 1.79
Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J Neurosci (2006) 1.79
Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size. Anesthesiology (2004) 1.78
mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci (2002) 1.77
The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol (2008) 1.75
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci (2009) 1.72
Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc Natl Acad Sci U S A (2004) 1.71
Association of substance use disorders with childhood trauma but not African genetic heritage in an African American cohort. Am J Psychiatry (2009) 1.70
Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry (2002) 1.70
Genetic approaches to addiction: genes and alcohol. Addiction (2008) 1.70
A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A (2010) 1.70
Retracted A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A (2008) 1.69
Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology (2010) 1.68
Early menopausal hormone use influences brain regions used for visual working memory. Menopause (2010) 1.67
Problem drinking and alcoholism: diagnosis and treatment. Am Fam Physician (2002) 1.67
A family of ductile intermetallic compounds. Nat Mater (2003) 1.66
Dimensional anxiety mediates linkage of GABRA2 haplotypes with alcoholism. Am J Med Genet B Neuropsychiatr Genet (2006) 1.64
Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet (2003) 1.64
Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A (2011) 1.62
Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol Psychiatry (2012) 1.61
Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology (2007) 1.60
Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum Mol Genet (2008) 1.60
Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59
Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res (2011) 1.58
Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry (2010) 1.57
Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proc Natl Acad Sci U S A (2008) 1.56
Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci (2006) 1.54
C9ORF72 expansion in a family with bipolar disorder. Bipolar Disord (2013) 1.54
Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis (2009) 1.53
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry (2006) 1.52
MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet (2004) 1.51
Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.50
Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry (2007) 1.50
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage (2009) 1.49